A research-use HCV NS5A genotyping and drug-resistance assay for PCR amplification from plasma or serum RNA, compatible with Sanger and NGS workflows.
The NS5A assay is a single-tube PCR system for amplifying relevant portions of the HCV NS5A gene from plasma or serum RNA. It may support HCV typing and drug-resistance workflows and is not positioned as a screening, confirmation, detection, or quantification test.
| Product | Reference |
|---|---|
| DeepChek Assay NS5A Genotyping and Drug Resistance (RUO) | 105A24 |
| Special Bundle: DeepChek Assay NS5A + NS3 + NS5B Genotyping & Drug Resistance (RUO) | 105A24 + 108A24 + 107D24 |
| DeepChek - HCV Software / Module (CE-IVD) | S12-023 (CL) / S12-023 (CM) |
A fit for NS5A-focused HCV drug-resistance workflows, especially when combined with NS3 and NS5B coverage.
Back To HCV PortfolioA research-use HCV genotyping assay focused on NS5B / 5'UTR amplification from plasma or serum RNA, with Sanger and NGS workflow compatibility.
View Details
A research-use HCV CORE genotyping assay for PCR amplification from plasma or serum RNA, compatible with Sanger and NGS workflows.
View Details
A research-use HCV NS3 genotyping and drug-resistance assay for PCR amplification from plasma or serum RNA, compatible with Sanger and NGS workflows.
View Details